The yeast p53 functional assay: A new tool for molecular epidemiology. Hopes and facts

Mutation Research - Reviews in Mutation Research

Volumn 462, Issue 2-3, 2000, Pages 293-301

  Fronza, Gilberto ^a   Inga, Alberto ^a   Monti, Paola ^a   Scott, Gina ^b   Campomenosi, Paola ^a   Menichini, Paola ^a   Ottaggio, Laura ^a   Viaggi, Silvia ^a,c   Burns, Philip A ^b   Gold, Barry ^d   Abbondandolo, Angelo ^a,c  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c UNIVERSITY OF GENOA   (Italy)

^d UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Mutation spectra; p53; Yeast functional assay

Indexed keywords

ALKYLATING AGENT; LOMUSTINE; METHYLNITROSOUREA; NITROSOUREA DERIVATIVE; PROTEIN P53;

BIOASSAY; CANCER EPIDEMIOLOGY; CARCINOGENESIS; DNA DAMAGE; HUMAN; MUTATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SKIN CANCER; ULTRAVIOLET RADIATION; YEAST;

EID: 0034086025     PISSN: 13835742     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5742(00)00011-9     Document Type: Article

References (41)

1. Hainaut P., Hernandez T., Robinson A., Rodriguez-Tome P., Flores T., Hollstein M., Harris C.C., Montesano R. IARC Database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation tools. Nucleic Acids Res. 26:1998;205-215.
2. Vogelstein B., Kinzler K.W. Carcinogens leave fingerprints. Nature. 355:1992;209-210.
3. Dogliotti E. Mutational spectra: from model systems to cancer related genes. Carcinogenesis. 17:1996;2113-2118.
4. Harris C.C. p53: at the crossroads of molecular carcinogenesis and risk assessment. Science. 262:1993;1980-1981.
5. Dogliotti E., Hainaut P., Hernandez T., D'Errico M., De Marini D.M. Mutation spectra resulting from carcinogenic exposure: from model systems to cancer related genes. Recent Results Cancer Res. 154:1998;97-124.
6. Holmquist G.P., Gao S. Somatic mutation theory, DNA repair rates, and the molecular epidemiology of p53 mutations. Mutat. Res. 386:1997;69-101.
7. Schaerer E., Iggo R. Mammalian p53 can function as a transcription factor in yeast. Nucleic Acids Res. 20:1992;1539-1545.
8. Inga A., Iannone R., Monti P., Molina F., Bolognesi M., Abbondandolo A., Iggo R., Fronza G. Determining mutational fingerprints at the human p53 locus with a yeast functional assay: a new tool for molecular epidemiology. Oncogene. 14:1997;1307-1313.
9. Inga A., Scott G., Monti P., Aprile A., Abbondandolo A., Burns P.A., Fronza G. Ultraviolet-light induced p53 mutational spectrum in yeast is indistinguishable from p53 mutations in human skin cancer. Carcinogenesis. 19:1998;741-746.
10. Inga A., Chen F.-X., Monti P., Aprile A., Campomenosi P., Menichini P., Ottaggio L., Viaggi S., Abbondandolo A., Gold B., Fronza G. N-(2-Chloroethyl)-n-nitrosourea tethered to lexitropsin induces minor groove lesions at the p53 cDNA which are more cytotoxic than mutagenic. Cancer Res. 59:1999;689-695.
11. Kelly J.D., Inga A., Chen F.-X., Dande P., Shah D., Monti P., Aprile A., Burns P.A., Scott G., Abbondandolo A., Gold B., Fronza G. Relationship between DNA methylation and mutational patterns induced by a sequence selective minor groove methylating agent. J. Biol. Chem. 274:1999;18327-18334.
12. Moshinsky D., Wogan G.N. UV-induced mutagenesis of human p53 in a vector replicated in S. cerevisiae. Proc. Natl. Acad. Sci. USA. 94:1997;2266-2271.
13. Murata J.-I., Tada M., Iggo R., Sawamura Y., Shinohe Y., Abe H. Nitric oxide as a carcinogen: analysis by yeast functional assay of inactivating p53 mutations induced by nitric oxide. Mutat. Res. 379:1997;211-218.
14. Flaman J.M., Frebourg T., Moreau V., Charbonnier F., Martin C., Chappuis P., Sappino A.-P., Limacher J.-M., Bron L., Benhattar J., Tada M., van Meir E.G., Estreicher A., Iggo R. A simple p53 functional assay for screening cell lines, blood, and tumors. Proc. Natl. Acad. Sci. USA. 92:1995;3963-3967.
15. Ory K., Legros Y., Auguin C., Soussi T. Analysis of the most representative tumour-derived p53 mutants reveals that changes in protein conformation are not correlated with loss of transactivation or inhibition of cell proliferation. EMBO J. 13:1994;3496-3504.
16. Pietenpol J.A., Tokino T., Thiagalingam S., El-Deiry W.S., Kinzler K.W., Vogelstein B. Sequence-specific transcriptional activation is essential for growth suppression by p53. Proc. Natl. Acad. Sci. USA. 91:1994;1998-2002.
17. Cariello N.F., Piegorsch W.W., Adams W.T., Skopek T.R. Computer programme for the analysis of mutational spectra: application to p53 mutations. Carcinogenesis. 15:1994;2281-2285.
18. Routledge M.N., Wink D.A., Keefer L.K., Dipple A. Mutations induced by saturated aqueous nitric oxide in the pSP189 supF gene in human Ad293 and E. coli MBM7070 cells. Carcinogenesis. 14:1993;1251-1254.
19. Kraemer K.H., Seidman M.M. Use of supF, an E. coli tyrosine suppressor tRNA gene, as a mutagenic target in shuttle vector plasmids. Mutat. Res. 220:1989;61-72.
20. Flaman J.M., Frebourg T., Moreau V., Charbonnier F., Martin C., Ishioka C., Friend S.H., Iggo R. PCR fidelity assay. Nucleic Acids Res. 22:1994;3259-3260.
21. Inga A., Iannone R., Campomenosi P., Molina F., Menichini P., Abbondandolo A., Fronza G. Mutational fingerprint of chloroethyl-cyclohexyl-nitroso-urea in mammalian cells. Cancer Res. 55:1995;4658-4663.
22. Miller J.H. Mutagenic specificity of ultraviolet light. J. Mol. Biol. 182:1985;45-68.
23. Bredberg A., Kraemer K.H., Seidman M.M. Restricted ultraviolet mutational spectrum in a shuttle vector propagated in Xeroderma pigmentosum cells. Proc. Natl. Acad. Sci. USA. 83:1986;8273-8277.
24. Drobetsky E.A., Grovosky A.J., Glickman B.W. The specificity of UV-induced mutations at an endogenous locus in mammalian cells. Proc. Natl. Acad. Sci. USA. 84:1987;9103-9107.
25. McGregor W.G., Chen R.H., Lubash L., Maher V.M., McCormick J.J. Cell cycle-dependent strand bias for UV-induced mutations in the transcribed strand of excision repair-proficient human fibroblasts but not in repair deficient cells. Mol. Cell. Biol. 11:1991;1927-1934.
26. 32P -end-labeled DNA Biochemistry. 29:1990;6827-6838.
27. Chen F.-X., Zhang Y., Church K.M., Bodell W.J., Gold B. DNA crosslinking, sister chromatid exchange and cytotoxicity of N-2-chloroethylnitrosoureas tethered to minor groove binding peptides. Carcinogenesis. 14:1993;935-940.
28. 32P )-end labeled DNA J. Am. Chem. Soc. 111:1989;6408-6412.
29. Hartley J.A., Gibson N.W., Kohn K.W., Mattes W.B. DNA sequence selectivity of guanine-N7 alkylation by three antitumor chloroethylagents. Cancer Res. 46:1986;1943-1947.
30. Brash D.E., Rudolph J.A., Simon J.A., Lin A., McKenna G.J., Baden H.P., Halperin A.J., Ponten J. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc. Natl. Acad. Sci. USA. 88:1991;10124-10128.
31. Matzumura Y., Nishigori C., Yagi T., Imamura S., Takebe H. Characterization of p53 gene mutations in basal-cell carcinomas: comparison between sun-exposed and less-exposed skin areas. Int. J. Cancer. 65:1996;778-780.
32. D'Errico M., Calcagnile A.S., Corona R., Fucci M., Annessi G., Baliva G., Tosti M.E., Pasquini P., Dogliotti E. p53 mutations and chromosome instability in basal cell carcinomas developed at an early or late age. Cancer Res. 57:1997;747-752.
33. Ziegler A., Leffell D.J., Kunala S., Sharma H.W., Gailani M., Simon J.A., Halperin A.J., Baden A.J., Shapiro P.E., Bale A.E., Brash D.E. Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancer. Proc. Natl. Acad. Sci. USA. 90:1993;4216-4220.
34. Ziegler A., Jonason A.S., Leffell D.J., Simon J.A., Sharma H.W., Kimmelman J., Remington L., Sacks T., Brash D.E. Sunburn and p53 in the onset of skin cancer. Nature. 372:1994;773-776.
35. Nakazawa H., English D., Randell P.L., Nakazawa K., Martel N., Amstrong B.K., Yamasaki H. UV and skin cancer: specific p53 gene mutations in normal skin as a biologically relevant exposure measurement. Proc. Natl. Acad. Sci. USA. 91:1994;360-364.
36. Jonason A.S., Kunala S., Price G.J., Restifo R.J., Spinelli H.M., Persing J.A., Leffell D.J., Tarone R.E., Brash D.E. Frequent clones of p53 mutated keratinocytes in normal human skin. Proc. Natl. Acad. Sci. USA. 93:1996;14025-14029.
37. Drouin R., Therrien J.-P. UVB-induced cyclobutan pyrimidine dimer frequency correlates with skin cancer mutational hotspots in p53. Photochem. Photobiol. 66:1997;719-726.
38. Tommasi S., Denissenko M.F., Pfeifer G.P. Sunlight induces pyrimidine dimers preferentially at 5-methylcytosine bases. Cancer Res. 57:1997;4727-4730.
39. Mitchell D.L., Jen J., Cleaver J.E. Sequence specificity of cyclobutane pyrymidine dimers in DNA treated with solar (ultraviolet B) radiation. Nucleic Acids Res. 20:1992;225-229.
40. Tornaletti S., Pfeifer G.P. Slow repair of pyrimidine dimers at the p53 mutation hotspot in skin cancer. Science. 263:1994;1436-1438.
41. Hollstein M., Moeckel G., Hergenhahn M., Spiegelhalder B., Keil M., Werle-Schneider G., Bartch H., Brickmann J. On the origins of tumor mutations in cancer genes: insights from the p53 gene. Mutat. Res. 405:1998;145-154.